SUCK ON THIS | GTFO or GTFO

Public health practitioners and state and local health departments can use this tool to promote tailored pharmacy-based interventions.

To develop and conduct an initial field test of the Drug Adherence Work-up (DRAW) tool, which was developed to guide pharmacists when addressing nonadherence during medication therapy management (MTM) visits.

phactMI- Your primary source for current, evidence-based drug information to support effective clinical decision making.

The estimated cost of medication non-adherence is 290 billion dollars per year in the United States alone, according to a report by CVS Health. Keeping

The independent investigation suggests that wirelessly observed therapies using Proteus' system could be considered equivalent to in-person medication adherence programs, but much better received by

Author summary Why was this study done? TB is the infectious disease that kills the most people annually and is spread by droplets released into the air from persons with TB in their lungs. Multiple antibiotics taken over many months are necessary to cure this infection, and if doses are missed or full treatment is not completed, infected people can continue spreading the disease, and antibiotic resistance may occur. New methods to confirm that all the correct medication doses are taken and support patients over the long treatment course are crucial to saving lives and combatting disease spread. What did the researchers do and find? We tested a new FDA-approved technology that uses a sensor made of minerals that is swallowed with TB medication and subsequently records the ingestion on a cellphone. We tested the sensor system accuracy to identify ingestions and we also randomly assigned persons with TB to receive the new system or the standard of care currently available, directly observed therapy, for supporting and confirming medication taking during TB treatment for periods up to 29 weeks. We found the system was highly accurate and that persons using this system were confirmed as taking 93% of their daily prescribed doses as opposed to 63% using directly observed therapy. In this study, the difference observed was mainly driven by the ability of the system to confirm doses 7 days a week compared to only on working days for directly observed therapy. What do these findings mean? These findings indicate that novel sensor-based systems that use cell phones to remotely record digital data are as accurate as actually watching a person swallow their medications and can be used to confirm and support TB treatment 7 days a week, compared to 5 days a week for the current standard of care available. However, this technology still needs to be tested over the full course of TB treatment. WOT should be tested in high-burden TB settings, where it may substantially support LMIC TB programs.

Author summary Why was this study done? TB is the infectious disease that kills the most people annually and is spread by droplets released into the air from persons with TB in their lungs. Multiple antibiotics taken over many months are necessary to cure this infection, and if doses are missed or full treatment is not completed, infected people can continue spreading the disease, and antibiotic resistance may occur. New methods to confirm that all the correct medication doses are taken and support patients over the long treatment course are crucial to saving lives and combatting disease spread. What did the researchers do and find? We tested a new FDA-approved technology that uses a sensor made of minerals that is swallowed with TB medication and subsequently records the ingestion on a cellphone. We tested the sensor system accuracy to identify ingestions and we also randomly assigned persons with TB to receive the new system or the standard of care currently available, directly observed therapy, for supporting and confirming medication taking during TB treatment for periods up to 29 weeks. We found the system was highly accurate and that persons using this system were confirmed as taking 93% of their daily prescribed doses as opposed to 63% using directly observed therapy. In this study, the difference observed was mainly driven by the ability of the system to confirm doses 7 days a week compared to only on working days for directly observed therapy. What do these findings mean? These findings indicate that novel sensor-based systems that use cell phones to remotely record digital data are as accurate as actually watching a person swallow their medications and can be used to confirm and support TB treatment 7 days a week, compared to 5 days a week for the current standard of care available. However, this technology still needs to be tested over the full course of TB treatment. WOT should be tested in high-burden TB settings, where it may substantially support LMIC TB programs.

Conclusions: The findings of this study suggest that digital medicines can be used for wirelessly observed therapy to support adherence to antiviral HCV therapy, reduce unnecessary medication wastage and retreatment costs, and potentially optimize sustained virologic response rates, especially in po …

Wirelessly Observed Therapy in Comparison to Directly Observed Therapy for the Treatment of Tuberculosis - Full Text View.

Despite the fact that osteoporosis is a growing public health problem in the United States and worldwide, there is poor adherence to medications to treat the problem. A recent study published in Osteoporosis International identified the factors that influence patient adherence to therapy, many of which are modifiable.

Non-adherence to hypertension treatment often resulted from patients' understanding of the causes and effects of hypertension; particularly relying on the presence of stress or symptoms to determine if blood pressure was raised. These beliefs were remarkably similar across ethnic and geographical gr …

The National Institute for Health Research Public Health Research programme.

There is little quantitative evidence of positive or negative health and well-being benefits from participating in EECA. However, the qualitative research showed high levels of perceived benefit among participants. Quantitative evidence resulted from study designs with high risk of bias, qualitative …

A panel of judges that includes former NSYNC band member Lance Bass debate, on air, whether to invest in biotech and health startups.

Intelligent search from Bing makes it easier to quickly find what you’re looking for and rewards you.

Provention Bio, Inc., (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, announced today that the U.S. Food and Drug Administration (FDA) posted briefing documents for the May 27, 2021 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)

Intelligent search from Bing makes it easier to quickly find what you’re looking for and rewards you.

Advisory Committees (Drugs)

Intelligent search from Bing makes it easier to quickly find what you’re looking for and rewards you.

Advisory Committees (Drugs)

USPHS USPHS PharmPAC last reviewed 10/13/2020

Intelligent search from Bing makes it easier to quickly find what you’re looking for and rewards you.